Work

The novel fungal CYP51 inhibitor VT-1598 displays classic dose-dependent antifungal activity in murine models of invasive aspergillosis

Year: 2019

Type: article

Source: Medical Mycology

DOI: 10.1093/mmy/myz092

Authors: E P Garvey, A D Sharp, P A Warn, C M Yates, M Atari, S Thomas, R J Schotzinger

Institutions: Viamet Pharmaceuticals (United States), Evotec (United Kingdom)

Language: English

Topic: Antifungal resistance and susceptibility

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: U.S. Army Medical Research Acquisition Activity

Award: G3821986886

OpenAlex ID: W3029648668

FWCI: 1.341

Cites: 25

Cited by: 20

Related to: 10